| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 1.03e-04 | 231 | 93 | 7 | GO:0005085 | |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 2.13e-04 | 5 | 93 | 2 | GO:0097109 | |
| GeneOntologyCellularComponent | XY body | 1.37e-04 | 23 | 92 | 3 | GO:0001741 | |
| MousePheno | shortened PR interval | 6.60e-06 | 23 | 76 | 4 | MP:0010511 | |
| MousePheno | sinus bradycardia | 5.38e-05 | 14 | 76 | 3 | MP:0010637 | |
| MousePheno | abnormal tail morphology | 6.20e-05 | 403 | 76 | 10 | MP:0002111 | |
| MousePheno | delayed bone ossification | 6.49e-05 | 127 | 76 | 6 | MP:0000060 | |
| MousePheno | enlarged tail bud | 8.72e-05 | 3 | 76 | 2 | MP:0003401 | |
| MousePheno | abnormal fibrous joint morphology | 9.12e-05 | 135 | 76 | 6 | MP:0030878 | |
| Domain | Ras_G-nucl-exch_fac_CS | 4.18e-05 | 14 | 93 | 3 | IPR019804 | |
| Domain | MAP1 | 7.33e-05 | 3 | 93 | 2 | IPR026074 | |
| Domain | RasGEFN | 1.28e-04 | 20 | 93 | 3 | SM00229 | |
| Domain | RasGEF_N | 1.49e-04 | 21 | 93 | 3 | PF00618 | |
| Domain | Ras-like_Gua-exchang_fac_N | 1.72e-04 | 22 | 93 | 3 | IPR000651 | |
| Domain | RASGEF_NTER | 1.72e-04 | 22 | 93 | 3 | PS50212 | |
| Domain | RASGEF | 2.86e-04 | 26 | 93 | 3 | PS00720 | |
| Domain | DUF3398 | 3.63e-04 | 6 | 93 | 2 | PF11878 | |
| Domain | DOCK_C/D_N | 3.63e-04 | 6 | 93 | 2 | IPR021816 | |
| Domain | RASGEF_CAT | 3.98e-04 | 29 | 93 | 3 | PS50009 | |
| Domain | RasGEF | 4.40e-04 | 30 | 93 | 3 | PF00617 | |
| Domain | - | 4.40e-04 | 30 | 93 | 3 | 1.10.840.10 | |
| Domain | Ras_GEF_dom | 4.40e-04 | 30 | 93 | 3 | IPR023578 | |
| Domain | RASGEF_cat_dom | 4.40e-04 | 30 | 93 | 3 | IPR001895 | |
| Domain | RasGEF | 4.40e-04 | 30 | 93 | 3 | SM00147 | |
| Domain | Syndecan | 5.07e-04 | 7 | 93 | 2 | PF01034 | |
| Domain | Syndecan/Neurexin_dom | 5.07e-04 | 7 | 93 | 2 | IPR027789 | |
| Domain | DOCK_C | 1.31e-03 | 11 | 93 | 2 | IPR010703 | |
| Domain | DHR-1_domain | 1.31e-03 | 11 | 93 | 2 | IPR027007 | |
| Domain | DHR_2 | 1.31e-03 | 11 | 93 | 2 | PS51651 | |
| Domain | DHR_1 | 1.31e-03 | 11 | 93 | 2 | PS51650 | |
| Domain | DOCK-C2 | 1.31e-03 | 11 | 93 | 2 | PF14429 | |
| Domain | DHR-2 | 1.31e-03 | 11 | 93 | 2 | IPR027357 | |
| Domain | DHR-2 | 1.31e-03 | 11 | 93 | 2 | PF06920 | |
| Domain | DOCK | 1.31e-03 | 11 | 93 | 2 | IPR026791 | |
| Domain | LamG | 1.37e-03 | 44 | 93 | 3 | SM00282 | |
| Domain | Neurexin-like | 2.15e-03 | 14 | 93 | 2 | IPR003585 | |
| Domain | 4.1m | 2.15e-03 | 14 | 93 | 2 | SM00294 | |
| Domain | ARM-like | 2.30e-03 | 270 | 93 | 6 | IPR011989 | |
| Domain | PH | 2.66e-03 | 278 | 93 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 2.71e-03 | 279 | 93 | 6 | PS50003 | |
| Domain | PH_domain | 2.76e-03 | 280 | 93 | 6 | IPR001849 | |
| Domain | Laminin_G | 3.03e-03 | 58 | 93 | 3 | IPR001791 | |
| Domain | TF_T-box | 3.18e-03 | 17 | 93 | 2 | IPR001699 | |
| Domain | TBOX | 3.18e-03 | 17 | 93 | 2 | SM00425 | |
| Domain | TF_T-box_CS | 3.18e-03 | 17 | 93 | 2 | IPR018186 | |
| Domain | - | 3.18e-03 | 17 | 93 | 2 | 2.60.40.820 | |
| Domain | TBOX_3 | 3.18e-03 | 17 | 93 | 2 | PS50252 | |
| Domain | T-box | 3.18e-03 | 17 | 93 | 2 | PF00907 | |
| Domain | TBOX_1 | 3.18e-03 | 17 | 93 | 2 | PS01283 | |
| Domain | TBOX_2 | 3.18e-03 | 17 | 93 | 2 | PS01264 | |
| Domain | DH_1 | 3.82e-03 | 63 | 93 | 3 | PS00741 | |
| Domain | BRCT | 3.97e-03 | 19 | 93 | 2 | PF00533 | |
| Domain | - | 4.40e-03 | 20 | 93 | 2 | 3.60.15.10 | |
| Domain | Metallo-B-lactamas | 4.40e-03 | 20 | 93 | 2 | IPR001279 | |
| Domain | RhoGEF | 4.74e-03 | 68 | 93 | 3 | SM00325 | |
| Pubmed | TBX3 RAD18 THRA ERF BRCA1 MAP1A CFAP36 CHAF1A BACH2 SCN5A CUL7 PIP4K2C CLSPN SRCAP MAST2 WDR37 PCM1 | 8.74e-09 | 1116 | 95 | 17 | 31753913 | |
| Pubmed | NCOR1 IRS4 KMT2B MAP1B PHACTR4 DOCK7 GIGYF2 EDC4 PATJ SRCAP PCM1 WDR44 | 3.54e-08 | 549 | 95 | 12 | 38280479 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | NCOR1 RAD18 MAP1A BACH2 DAXX CUL7 PIP4K2C CLSPN PATJ SRCAP DNMBP PCM1 | 7.45e-08 | 588 | 95 | 12 | 38580884 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | IRS4 GPBP1 MAP1B EXPH5 SRGAP1 ROR2 PHACTR4 DOCK7 GIGYF2 EDC4 PATJ MAST2 DNMBP PCM1 | 9.35e-08 | 861 | 95 | 14 | 36931259 |
| Pubmed | 2.65e-07 | 233 | 95 | 8 | 37704626 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOR1 RAD18 ZEB1 KMT2B CHAF1A PHACTR4 RRP15 GIGYF2 DAXX DNMBP PCM1 WDR44 | 1.37e-06 | 774 | 95 | 12 | 15302935 |
| Pubmed | Identification of 14-3-3epsilon substrates from embryonic murine brain. | 1.76e-06 | 132 | 95 | 6 | 16944949 | |
| Pubmed | A conserved acetylation switch enables pharmacological control of tubby-like protein stability. | 2.78e-06 | 223 | 95 | 7 | 33187986 | |
| Pubmed | 3.21e-06 | 11 | 95 | 3 | 31286143 | ||
| Pubmed | 4.23e-06 | 87 | 95 | 5 | 12465718 | ||
| Pubmed | 4.43e-06 | 40 | 95 | 4 | 28805822 | ||
| Pubmed | RASGRF2 controls nuclear migration in postnatal retinal cone photoreceptors. | 7.38e-06 | 2 | 95 | 2 | 26743081 | |
| Pubmed | Caspase-3 mediated cleavage of BRCA1 during UV-induced apoptosis. | 7.38e-06 | 2 | 95 | 2 | 12149654 | |
| Pubmed | Regulation of microtubule-associated protein 1B (MAP1B) subunit composition. | 7.38e-06 | 2 | 95 | 2 | 11002287 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 15131262 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 16467520 | ||
| Pubmed | NCOR1 modulates erythroid disorders caused by mutations of thyroid hormone receptor α1. | 7.38e-06 | 2 | 95 | 2 | 29273766 | |
| Pubmed | Decapping protein EDC4 regulates DNA repair and phenocopies BRCA1. | 7.38e-06 | 2 | 95 | 2 | 29511213 | |
| Pubmed | Human Claspin works with BRCA1 to both positively and negatively regulate cell proliferation. | 7.38e-06 | 2 | 95 | 2 | 15096610 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 17141611 | ||
| Pubmed | DNA repair factor BRCA1 depletion occurs in Alzheimer brains and impairs cognitive function in mice. | 7.38e-06 | 2 | 95 | 2 | 26615780 | |
| Pubmed | Multiple mechanisms regulate H3 acetylation of enhancers in response to thyroid hormone. | 7.38e-06 | 2 | 95 | 2 | 32453730 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 16996626 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 19193896 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 14749369 | ||
| Pubmed | The mouse and rat MAP1B genes: genomic organization and alternative transcription. | 7.38e-06 | 2 | 95 | 2 | 9615228 | |
| Pubmed | Daxx contains two nuclear localization signals and interacts with importin alpha3. | 7.38e-06 | 2 | 95 | 2 | 17661348 | |
| Pubmed | A murine CDC25/ras-GRF-related protein implicated in Ras regulation. | 7.38e-06 | 2 | 95 | 2 | 8293576 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 9199175 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 7806212 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 23610395 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 28966131 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 31023256 | ||
| Pubmed | A histone deacetylase inhibitor improves hypothyroidism caused by a TRα1 mutant. | 7.38e-06 | 2 | 95 | 2 | 24381310 | |
| Pubmed | The Inhibition of RasGRF2, But Not RasGRF1, Alters Cocaine Reward in Mice. | 7.38e-06 | 2 | 95 | 2 | 31182637 | |
| Pubmed | Neuronal abnormalities in microtubule-associated protein 1B mutant mice. | 7.38e-06 | 2 | 95 | 2 | 8577753 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 2355215 | ||
| Pubmed | NCOR1 ASXL1 RAD18 IRS4 ZEB1 ERF KMT2B BRCA1 RRP15 GIGYF2 CUL7 EDC4 SRCAP CAPRIN1 PCM1 | 7.50e-06 | 1429 | 95 | 15 | 35140242 | |
| Pubmed | 7.66e-06 | 486 | 95 | 9 | 20936779 | ||
| Pubmed | 9.24e-06 | 102 | 95 | 5 | 10231032 | ||
| Pubmed | 1.18e-05 | 650 | 95 | 10 | 38777146 | ||
| Pubmed | Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes. | 1.38e-05 | 53 | 95 | 4 | 21532573 | |
| Pubmed | 1.56e-05 | 18 | 95 | 3 | 19640993 | ||
| Pubmed | 1.85e-05 | 19 | 95 | 3 | 20504901 | ||
| Pubmed | 1.85e-05 | 19 | 95 | 3 | 22398208 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | PIK3AP1 NCOR1 GPBP1 BACH2 PHACTR4 DYNC2I1 GIGYF2 MAST2 DNMBP LRP1B PCM1 | 2.17e-05 | 853 | 95 | 11 | 28718761 |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 38891114 | ||
| Pubmed | RasGRF suppresses Cdc42-mediated tumour cell movement, cytoskeletal dynamics and transformation. | 2.21e-05 | 3 | 95 | 2 | 21685891 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 16406382 | ||
| Pubmed | Targeted disruption of Ras-Grf2 shows its dispensability for mouse growth and development. | 2.21e-05 | 3 | 95 | 2 | 11909944 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 24664738 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 31005376 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 16478718 | ||
| Pubmed | Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity. | 2.21e-05 | 3 | 95 | 2 | 16061635 | |
| Pubmed | Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals. | 2.21e-05 | 3 | 95 | 2 | 26446217 | |
| Pubmed | Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. | 2.21e-05 | 3 | 95 | 2 | 11944992 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 33058888 | ||
| Pubmed | Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules. | 2.21e-05 | 3 | 95 | 2 | 17035546 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 9448462 | ||
| Pubmed | Deletion of α-neurexin II results in autism-related behaviors in mice. | 2.21e-05 | 3 | 95 | 2 | 25423136 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 15029245 | ||
| Pubmed | Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior. | 2.21e-05 | 3 | 95 | 2 | 34133920 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 30858964 | ||
| Pubmed | In vivo repression of an erythroid-specific gene by distinct corepressor complexes. | 2.21e-05 | 3 | 95 | 2 | 11889044 | |
| Pubmed | Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways. | 2.21e-05 | 3 | 95 | 2 | 26029931 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 2470876 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 28013231 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 31812984 | ||
| Pubmed | Microtubule-associated proteins, MAP 1A and MAP 1B, interact with F-actin in vitro. | 2.21e-05 | 3 | 95 | 2 | 7908020 | |
| Pubmed | Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. | 2.21e-05 | 3 | 95 | 2 | 12036300 | |
| Pubmed | β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. | 2.21e-05 | 3 | 95 | 2 | 26213384 | |
| Pubmed | Neurexin gene family variants as risk factors for autism spectrum disorder. | 2.21e-05 | 3 | 95 | 2 | 29045040 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 38571813 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 35173587 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 17278098 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 9804773 | ||
| Pubmed | Neurexins are differentially expressed in the embryonic nervous system of mice. | 2.21e-05 | 3 | 95 | 2 | 7722633 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 18052923 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 23152929 | ||
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | 2.51e-05 | 432 | 95 | 8 | 23455922 | |
| Pubmed | PIK3AP1 ZBTB20 TXLNB GPBP1 CNST OSBPL5 CCND1 WDR37 HORMAD1 WDR44 | 2.82e-05 | 720 | 95 | 10 | 16381901 | |
| Pubmed | PIK3AP1 ZBTB20 TXLNB GPBP1 CNST OSBPL5 CCND1 WDR37 HORMAD1 WDR44 | 2.89e-05 | 722 | 95 | 10 | 15489336 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | PARP4 BRCA1 MAP1A MAP1B COPG1 DOCK7 GIGYF2 DAXX DNMBP CAPRIN1 | 2.96e-05 | 724 | 95 | 10 | 36232890 |
| Pubmed | 3.15e-05 | 446 | 95 | 8 | 24255178 | ||
| Pubmed | RIN1 MAP1A MAP1B NRXN2 DOCK8 CRACDL PDE4DIP DOCK7 EDC4 PIP4K2C WDR37 CAPRIN1 JMY PCM1 | 3.39e-05 | 1431 | 95 | 14 | 37142655 | |
| Pubmed | 3.79e-05 | 334 | 95 | 7 | 30425250 | ||
| Pubmed | Sucrose non-fermenting related kinase enzyme is essential for cardiac metabolism. | 3.83e-05 | 24 | 95 | 3 | 25505152 | |
| Pubmed | PIK3AP1 ZBTB20 TXLNB GPBP1 CNST OSBPL5 CD320 WDR37 HORMAD1 WDR44 | 3.98e-05 | 750 | 95 | 10 | 11230166 | |
| Pubmed | 4.35e-05 | 25 | 95 | 3 | 25664857 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 18559551 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 15601836 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 22863316 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 32706374 | ||
| Pubmed | Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression. | 4.41e-05 | 4 | 95 | 2 | 24870244 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 19692568 | ||
| Pubmed | Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells. | 4.41e-05 | 4 | 95 | 2 | 17334399 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 9849963 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 8786425 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 17347997 | ||
| Pubmed | RasGRF Couples Nox4-Dependent Endoplasmic Reticulum Signaling to Ras. | 4.41e-05 | 4 | 95 | 2 | 27856453 | |
| Interaction | YWHAZ interactions | RIN1 NCOR1 ASXL1 ADRA2B IRS4 BRCA1 GPBP1 RASGRF1 RASGRF2 EXPH5 SRGAP1 CHAF1A ROR2 PHACTR4 DOCK7 GIGYF2 CUL7 MAST2 WDR37 DNMBP SUCO DEK ZRANB1 PCM1 | 6.72e-09 | 1319 | 95 | 24 | int:YWHAZ |
| Interaction | YWHAE interactions | RIN1 RAD18 IRS4 BRCA1 GPBP1 MAP1B RASGRF1 DOCK8 EXPH5 SRGAP1 CHAF1A PHACTR4 DOCK7 CASP3 GIGYF2 CUL7 MAST2 WDR37 DNMBP ZRANB1 CAPRIN1 PCM1 | 6.46e-08 | 1256 | 95 | 22 | int:YWHAE |
| Interaction | YWHAH interactions | RIN1 IRS4 THRA GPBP1 EXPH5 SRGAP1 ROR2 PHACTR4 OSBPL5 DOCK7 GIGYF2 EDC4 PATJ MAST2 WDR37 DNMBP SUCO ZRANB1 PCM1 | 7.66e-07 | 1102 | 95 | 19 | int:YWHAH |
| Interaction | YWHAB interactions | RIN1 IRS4 RASGRF1 EXPH5 SRGAP1 CHAF1A ROR2 PHACTR4 DOCK7 GIGYF2 CUL7 PIP4K2C MAST2 WDR37 DNMBP SUCO ZRANB1 PCM1 | 1.04e-06 | 1014 | 95 | 18 | int:YWHAB |
| Interaction | YWHAG interactions | RIN1 IRS4 GPBP1 EXPH5 SRGAP1 CHAF1A ROR2 PHACTR4 DOCK7 CASP3 GIGYF2 CUL7 EDC4 PATJ MAST2 WDR37 DNMBP SUCO ZRANB1 PCM1 | 1.17e-06 | 1248 | 95 | 20 | int:YWHAG |
| Interaction | MCRS1 interactions | 1.68e-06 | 235 | 95 | 9 | int:MCRS1 | |
| Interaction | CSNK2A1 interactions | KPNA4 NCOR1 ASXL1 RAD18 IRS4 ZEB1 KMT2B BRCA1 CCDC82 RRP15 DAXX CUL7 PIP4K2C DNAJB2 DEK ZRANB1 WDR44 | 2.11e-06 | 956 | 95 | 17 | int:CSNK2A1 |
| Interaction | TK1 interactions | 2.22e-06 | 243 | 95 | 9 | int:TK1 | |
| Interaction | CAD interactions | ASXL1 NRBP2 ZEB1 BRCA1 MAP1B CHAF1A CASP3 GIGYF2 CCND1 CUL7 ZRANB1 | 4.39e-06 | 418 | 95 | 11 | int:CAD |
| Interaction | WWTR1 interactions | NCOR1 IRS4 ZEB1 MAP1B PHACTR4 DOCK7 EDC4 PATJ SRCAP PCM1 WDR44 | 4.80e-06 | 422 | 95 | 11 | int:WWTR1 |
| Interaction | BAG2 interactions | NCOR1 ASXL1 RAD18 MAP1B EXPH5 PHACTR4 DOCK7 CCND1 CUL7 EDC4 HPS5 DNAJB2 ZRANB1 | 6.97e-06 | 622 | 95 | 13 | int:BAG2 |
| Interaction | FAM161A interactions | 9.09e-06 | 156 | 95 | 7 | int:FAM161A | |
| Interaction | RBBP4 interactions | KPNA4 NCOR1 ASXL1 RAD18 ZEB1 ZBTB20 BRCA1 CHAF1A CCND1 CUL7 ZRANB1 CAPRIN1 | 1.59e-05 | 573 | 95 | 12 | int:RBBP4 |
| Interaction | YWHAQ interactions | IRS4 THRA BRCA1 GPBP1 EXPH5 SRGAP1 CHAF1A ROR2 PHACTR4 DOCK7 CUL7 MAST2 WDR37 DNMBP SUCO ZRANB1 PCM1 | 1.67e-05 | 1118 | 95 | 17 | int:YWHAQ |
| Interaction | PPARD interactions | 1.92e-05 | 117 | 95 | 6 | int:PPARD | |
| Interaction | DBF4 interactions | 1.93e-05 | 34 | 95 | 4 | int:DBF4 | |
| Interaction | TUBB6 interactions | 1.96e-05 | 243 | 95 | 8 | int:TUBB6 | |
| Interaction | GRB7 interactions | 2.14e-05 | 178 | 95 | 7 | int:GRB7 | |
| Interaction | UBXN6 interactions | 2.30e-05 | 325 | 95 | 9 | int:UBXN6 | |
| Interaction | AFDN interactions | 2.78e-05 | 333 | 95 | 9 | int:AFDN | |
| Interaction | PRKCSH interactions | 2.93e-05 | 257 | 95 | 8 | int:PRKCSH | |
| Interaction | TBL1XR1 interactions | 3.48e-05 | 192 | 95 | 7 | int:TBL1XR1 | |
| Interaction | CSNK2B interactions | ERICH1 RAD18 KMT2B BRCA1 CCDC82 RRP15 DAXX CUL7 PIP4K2C CLSPN DEK ZRANB1 | 3.72e-05 | 625 | 95 | 12 | int:CSNK2B |
| Interaction | MORC3 interactions | 3.81e-05 | 80 | 95 | 5 | int:MORC3 | |
| Interaction | GCN1 interactions | 4.01e-05 | 349 | 95 | 9 | int:GCN1 | |
| Interaction | BPTF interactions | 4.10e-05 | 197 | 95 | 7 | int:BPTF | |
| Interaction | ARL16 interactions | 4.55e-05 | 83 | 95 | 5 | int:ARL16 | |
| Interaction | CBX3 interactions | ERICH1 NCOR1 RAD18 ZEB1 KMT2B BRCA1 CHAF1A DAXX CUL7 CLSPN DEK ZRANB1 | 5.12e-05 | 646 | 95 | 12 | int:CBX3 |
| Interaction | MKI67 interactions | KPNA4 BRCA1 MAP1B OSBPL5 DOCK7 RRP15 DAXX CCND1 CUL7 DNMBP ZRANB1 CAPRIN1 | 5.27e-05 | 648 | 95 | 12 | int:MKI67 |
| Interaction | TERF2IP interactions | KPNA4 ERICH1 NCOR1 RAD18 ZEB1 KMT2B BRCA1 CHAF1A CLSPN SRCAP ZRANB1 | 5.76e-05 | 552 | 95 | 11 | int:TERF2IP |
| Interaction | CDKN1A interactions | 6.98e-05 | 375 | 95 | 9 | int:CDKN1A | |
| Interaction | MAGED1 interactions | 7.74e-05 | 295 | 95 | 8 | int:MAGED1 | |
| Interaction | EMD interactions | NCOR1 ASXL1 TBX3 IRS4 ZEB1 THRA DNAJC14 COPG1 ROR2 GIGYF2 CUL7 SUCO ZRANB1 | 8.29e-05 | 789 | 95 | 13 | int:EMD |
| Interaction | SMARCC1 interactions | 8.37e-05 | 384 | 95 | 9 | int:SMARCC1 | |
| Interaction | CDK8 interactions | 8.70e-05 | 222 | 95 | 7 | int:CDK8 | |
| Interaction | SFN interactions | IRS4 GPBP1 MAP1A MAP1B EXPH5 ROR2 DOCK7 EDC4 MAST2 DNMBP DEK ZRANB1 | 9.85e-05 | 692 | 95 | 12 | int:SFN |
| Interaction | TNPO1 interactions | 9.98e-05 | 306 | 95 | 8 | int:TNPO1 | |
| Interaction | PRKDC interactions | NCOR1 ASXL1 RAD18 NRBP2 ZEB1 THRA BRCA1 MAP1B CHAF1A CASP3 CUL7 ZRANB1 | 1.03e-04 | 695 | 95 | 12 | int:PRKDC |
| Interaction | CREBBP interactions | NCOR1 ZEB1 THRA BRCA1 GPBP1 MAP1B CHAF1A DAXX CCND1 SRCAP DEK | 1.19e-04 | 599 | 95 | 11 | int:CREBBP |
| Interaction | RAC1 interactions | KPNA4 USP6 IRS4 RASGRF1 RASGRF2 DOCK8 CFAP36 SRGAP1 ROR2 PHACTR4 DOCK7 CASP3 CD320 DNMBP ZRANB1 | 1.29e-04 | 1063 | 95 | 15 | int:RAC1 |
| Interaction | NOLC1 interactions | 1.51e-04 | 325 | 95 | 8 | int:NOLC1 | |
| Interaction | NRIP1 interactions | 1.54e-04 | 170 | 95 | 6 | int:NRIP1 | |
| Interaction | HSPB8 interactions | 1.64e-04 | 172 | 95 | 6 | int:HSPB8 | |
| Interaction | AFP interactions | 1.68e-04 | 23 | 95 | 3 | int:AFP | |
| Interaction | DHX16 interactions | 1.70e-04 | 173 | 95 | 6 | int:DHX16 | |
| Interaction | SULT1C4 interactions | 1.73e-04 | 110 | 95 | 5 | int:SULT1C4 | |
| Interaction | RFC2 interactions | 1.75e-04 | 174 | 95 | 6 | int:RFC2 | |
| Interaction | ASF1A interactions | 1.77e-04 | 249 | 95 | 7 | int:ASF1A | |
| Interaction | PPP1CC interactions | KPNA4 NCOR1 RAD18 BRCA1 CNST RNF19B PHACTR4 RRP15 CCND1 CUL7 WDR37 ZRANB1 | 1.80e-04 | 738 | 95 | 12 | int:PPP1CC |
| Interaction | MLF1 interactions | 1.97e-04 | 113 | 95 | 5 | int:MLF1 | |
| Interaction | CREB1 interactions | 2.00e-04 | 254 | 95 | 7 | int:CREB1 | |
| Interaction | HDAC1 interactions | KPNA4 NCOR1 TBX3 IRS4 ZEB1 KMT2B BRCA1 CHAF1A DOCK7 GIGYF2 DAXX CCND1 ZRANB1 CAPRIN1 PCM1 | 2.03e-04 | 1108 | 95 | 15 | int:HDAC1 |
| Interaction | H3-3A interactions | KPNA4 ERICH1 RAD18 KMT2B BRCA1 CHAF1A OSBPL5 DYNC2I1 RRP15 DAXX SRCAP DEK | 2.06e-04 | 749 | 95 | 12 | int:H3-3A |
| Interaction | HDAC2 interactions | KPNA4 NCOR1 TBX3 ZEB1 THRA BRCA1 CHAF1A DAXX CCND1 CUL7 DEK ZRANB1 CAPRIN1 | 2.06e-04 | 865 | 95 | 13 | int:HDAC2 |
| Interaction | LPXN interactions | 2.13e-04 | 115 | 95 | 5 | int:LPXN | |
| Interaction | SOHLH1 interactions | 2.13e-04 | 115 | 95 | 5 | int:SOHLH1 | |
| Interaction | CETN1 interactions | 2.23e-04 | 63 | 95 | 4 | int:CETN1 | |
| Interaction | TULP3 interactions | 2.31e-04 | 346 | 95 | 8 | int:TULP3 | |
| Interaction | AVEN interactions | 2.44e-04 | 26 | 95 | 3 | int:AVEN | |
| Interaction | B4GALT2 interactions | 2.50e-04 | 119 | 95 | 5 | int:B4GALT2 | |
| Interaction | MIF interactions | 2.53e-04 | 264 | 95 | 7 | int:MIF | |
| Interaction | HSPH1 interactions | 2.65e-04 | 448 | 95 | 9 | int:HSPH1 | |
| Interaction | APEX1 interactions | USP6 RAD18 ZEB1 KMT2B BRCA1 CHAF1A FLAD1 R3HCC1 RRP15 GIGYF2 DAXX SRCAP SUCO DEK ZRANB1 PCM1 | 2.78e-04 | 1271 | 95 | 16 | int:APEX1 |
| Interaction | SP110 interactions | 2.81e-04 | 122 | 95 | 5 | int:SP110 | |
| Interaction | DMAP1 interactions | 2.89e-04 | 191 | 95 | 6 | int:DMAP1 | |
| Interaction | MSH6 interactions | 2.97e-04 | 271 | 95 | 7 | int:MSH6 | |
| Interaction | HSPA4 interactions | FOCAD NCOR1 IRS4 ZEB1 THRA BRCA1 MAP1B EXPH5 DNMBP DNAJB2 ZRANB1 | 3.01e-04 | 667 | 95 | 11 | int:HSPA4 |
| Interaction | PARG interactions | 3.05e-04 | 28 | 95 | 3 | int:PARG | |
| Interaction | EWSR1 interactions | ERICH1 NCOR1 TBX3 ZEB1 BRCA1 CNST CHAF1A RRP15 CUL7 WDR37 LRP1B ZRANB1 PCM1 | 3.23e-04 | 906 | 95 | 13 | int:EWSR1 |
| Interaction | SAFB2 interactions | 3.23e-04 | 195 | 95 | 6 | int:SAFB2 | |
| Interaction | SMARCB1 interactions | 3.25e-04 | 364 | 95 | 8 | int:SMARCB1 | |
| Interaction | EEF1AKMT3 interactions | 3.25e-04 | 364 | 95 | 8 | int:EEF1AKMT3 | |
| Interaction | SRGAP2 interactions | 3.41e-04 | 197 | 95 | 6 | int:SRGAP2 | |
| Interaction | CCT6A interactions | 3.54e-04 | 570 | 95 | 10 | int:CCT6A | |
| Interaction | ADNP interactions | 3.60e-04 | 199 | 95 | 6 | int:ADNP | |
| Interaction | JUN interactions | 3.77e-04 | 470 | 95 | 9 | int:JUN | |
| Interaction | TNRC6B interactions | 3.77e-04 | 282 | 95 | 7 | int:TNRC6B | |
| Interaction | RCC1 interactions | 3.80e-04 | 201 | 95 | 6 | int:RCC1 | |
| Interaction | DPY30 interactions | 4.11e-04 | 204 | 95 | 6 | int:DPY30 | |
| Interaction | FAM133B interactions | 4.14e-04 | 31 | 95 | 3 | int:FAM133B | |
| Interaction | CAPN10 interactions | 4.56e-04 | 32 | 95 | 3 | int:CAPN10 | |
| Interaction | TRIM28 interactions | KPNA4 NCOR1 ASXL1 RAD18 IRS4 BRCA1 MAP1A MAP1B COPG1 CHAF1A CASP3 DAXX CCND1 CUL7 EDC4 SRCAP ZRANB1 | 4.86e-04 | 1474 | 95 | 17 | int:TRIM28 |
| Interaction | LCMT1 interactions | 5.00e-04 | 33 | 95 | 3 | int:LCMT1 | |
| Interaction | ZZZ3 interactions | 5.12e-04 | 139 | 95 | 5 | int:ZZZ3 | |
| Interaction | PARD3 interactions | 5.24e-04 | 298 | 95 | 7 | int:PARD3 | |
| Interaction | HMGA2 interactions | 5.29e-04 | 140 | 95 | 5 | int:HMGA2 | |
| Interaction | SMN1 interactions | 5.35e-04 | 299 | 95 | 7 | int:SMN1 | |
| Interaction | USO1 interactions | 5.43e-04 | 215 | 95 | 6 | int:USO1 | |
| Interaction | TADA3 interactions | 5.46e-04 | 141 | 95 | 5 | int:TADA3 | |
| Interaction | DNAJB8 interactions | 5.57e-04 | 80 | 95 | 4 | int:DNAJB8 | |
| Interaction | DNAI2 interactions | 5.57e-04 | 80 | 95 | 4 | int:DNAI2 | |
| Interaction | LINC02370 interactions | 6.04e-04 | 8 | 95 | 2 | int:LINC02370 | |
| Interaction | ZBTB45 interactions | 6.04e-04 | 8 | 95 | 2 | int:ZBTB45 | |
| Interaction | SERPINH1 interactions | 6.14e-04 | 306 | 95 | 7 | int:SERPINH1 | |
| Interaction | ZNF408 interactions | 6.20e-04 | 145 | 95 | 5 | int:ZNF408 | |
| Interaction | NCOA1 interactions | 6.40e-04 | 146 | 95 | 5 | int:NCOA1 | |
| Interaction | D2HGDH interactions | 6.40e-04 | 146 | 95 | 5 | int:D2HGDH | |
| Interaction | SEC61A1 interactions | 6.57e-04 | 223 | 95 | 6 | int:SEC61A1 | |
| Interaction | PFN1 interactions | 6.69e-04 | 509 | 95 | 9 | int:PFN1 | |
| Interaction | ARRDC3 interactions | 6.73e-04 | 224 | 95 | 6 | int:ARRDC3 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.54e-04 | 181 | 51 | 5 | 694 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.54e-04 | 66 | 51 | 3 | 722 | |
| GeneFamily | T-boxes | 1.16e-03 | 18 | 51 | 2 | 766 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.69e-03 | 206 | 51 | 4 | 682 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.97e-08 | 180 | 95 | 9 | M8239 | |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 8.49e-06 | 200 | 95 | 7 | M291 | |
| Coexpression | GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN | 8.49e-06 | 200 | 95 | 7 | M9260 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP6 ASXL1 ZEB1 ZBTB20 BRCA1 MAP1B GIGYF2 CCND1 MAST2 WDR37 DNMBP SUCO DEK | 1.29e-05 | 856 | 95 | 13 | M4500 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | KPNA4 AREL1 ZEB1 CNST BACH2 RNF19B CASP3 GIGYF2 SUCO ZRANB1 JMY | 3.58e-05 | 680 | 95 | 11 | M41089 |
| Coexpression | KAUFFMANN_MELANOMA_RELAPSE_UP | 7.21e-05 | 61 | 95 | 4 | M2431 | |
| Coexpression | GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_DN | 7.66e-05 | 194 | 95 | 6 | M7568 | |
| Coexpression | GSE8515_IL1_VS_IL6_4H_STIM_MAC_DN | 7.66e-05 | 194 | 95 | 6 | M5767 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_DN | CEP68 RAD18 NRXN3 BRCA1 DOCK8 RGL3 CHAF1A CCND1 CD320 CLSPN PATJ FAM131B RNF182 | 8.13e-05 | 1023 | 95 | 13 | M17122 |
| Coexpression | GSE11057_CD4_CENT_MEM_VS_PBMC_UP | 8.57e-05 | 198 | 95 | 6 | M3116 | |
| Coexpression | GSE360_DC_VS_MAC_L_MAJOR_DN | 8.81e-05 | 199 | 95 | 6 | M5182 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN | 9.05e-05 | 200 | 95 | 6 | M9341 | |
| Coexpression | GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN | 9.05e-05 | 200 | 95 | 6 | M9765 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP | 9.05e-05 | 200 | 95 | 6 | M8484 | |
| Coexpression | GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP | 9.05e-05 | 200 | 95 | 6 | M9258 | |
| Coexpression | BENPORATH_CYCLING_GENES | ASXL1 RAD18 BRCA1 CHAF1A FLAD1 CASP3 CCND1 CLSPN PATJ HORMAD1 | 1.22e-04 | 648 | 95 | 10 | M8156 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | PIK3AP1 TBX3 ADRA2B IRS4 COL15A1 DMRT2 RASGRF1 RASGRF2 DOCK8 ROR2 SCN5A CCND1 CLSPN | 1.32e-04 | 1074 | 95 | 13 | M1941 |
| Coexpression | GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_DN | 1.65e-04 | 141 | 95 | 5 | M465 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 2.71e-07 | 201 | 94 | 9 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500 | NCOR1 ZBTB20 MAP1B RASGRF1 DOCK8 CASP3 GIGYF2 CCND1 PATJ CAPRIN1 JMY | 1.65e-06 | 402 | 94 | 11 | gudmap_developingKidney_e15.5_anlage of loop of Henle_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | KPNA4 NCOR1 ZBTB20 COL15A1 MAP1B RASGRF1 DOCK8 CASP3 GIGYF2 CCND1 PATJ DNMBP SUCO CAPRIN1 JMY | 2.06e-06 | 795 | 94 | 15 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | TBX3 IRS4 MAP1B SRGAP1 CRACDL BACH2 ROR2 CASP3 GIGYF2 PATJ CAPRIN1 JMY PDZD2 | 5.43e-05 | 806 | 94 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | NRXN3 ZBTB20 BRCA1 MAP1A MAP1B NRXN2 CHAF1A DYNC2I1 CLSPN DEK | 6.57e-05 | 493 | 94 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.31e-04 | 339 | 94 | 8 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | TBX3 ZBTB20 RASGRF2 DOCK8 RGL3 CASP3 GIGYF2 PATJ SRCAP SUCO CAPRIN1 JMY | 1.56e-04 | 774 | 94 | 12 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-07 | 193 | 95 | 7 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | mild_COVID-19-B_cell|World / disease group, cell group and cell class (v2) | 6.39e-07 | 143 | 95 | 6 | 4698cc877dda9b1ef7d6f18c9adc869ef791b1d8 | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 9.13e-07 | 152 | 95 | 6 | f944743f40ff6ed3a7a096dd53e12d3526c67c4d | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-06 | 168 | 95 | 6 | 94cded2e953c0970bf2f3dbe0ce46bd77a5ed8c7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-06 | 186 | 95 | 6 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-06 | 189 | 95 | 6 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.33e-06 | 190 | 95 | 6 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.54e-06 | 192 | 95 | 6 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | MS-Treg-exh_CD4|MS / Condition, Cell_class and T cell subcluster | 3.54e-06 | 192 | 95 | 6 | c6722bf142c84ccedd99c1a3344085aecb4cbab4 | |
| ToppCell | MatrixFB-Fibroblast-B_(Myofibroblast)|MatrixFB / shred on cell class and cell subclass (v4) | 3.99e-06 | 196 | 95 | 6 | 38ea0eaf42f95c321ca23570d0d7752980cf00f8 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-new|World / Primary Cells by Cluster | 4.23e-06 | 198 | 95 | 6 | 11d2d4d179bc31ef2897d7ceeaf9bed1b20cbdc0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.23e-06 | 198 | 95 | 6 | 52ddc1f1ed4ac4c3bac794c90b8feb03e3c221c4 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-new-9|World / Primary Cells by Cluster | 4.23e-06 | 198 | 95 | 6 | c724ef958e14e17a7d8c02b9f842510c0780f635 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 4.48e-06 | 200 | 95 | 6 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | mild-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.48e-06 | 200 | 95 | 6 | c825320599a61a4c629d736f5c0fd6f1f405540a | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_T_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.05e-05 | 155 | 95 | 5 | e2c901d5c9e42d25d7702e5e8fc19b06f7c817be | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 3.02e-05 | 168 | 95 | 5 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.29e-05 | 171 | 95 | 5 | f3bf5805823d5733b58742172e7668725ce82931 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.29e-05 | 171 | 95 | 5 | 714a0b0d0c9886fef64170cf53eb64f0d8a47280 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.57e-05 | 174 | 95 | 5 | a1f745962a104c6f4b86b7e482da8755384c773a | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.57e-05 | 174 | 95 | 5 | c529f3674b784f872f4387ffdeb46aecb619976b | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.67e-05 | 175 | 95 | 5 | 78a86cac3e6c0d115c997d1c29ee0e24af54551f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.77e-05 | 176 | 95 | 5 | 07abf29d681abdd6c7cc87f9eaf9377e92ce212c | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-05 | 176 | 95 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.98e-05 | 178 | 95 | 5 | 5d6297f34e104bacefb25c4e2338b50fe13dd19a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.31e-05 | 181 | 95 | 5 | 098dbb3e0ff531c9720a233123250c1e39a97d4c | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 4.54e-05 | 183 | 95 | 5 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.54e-05 | 183 | 95 | 5 | 1645d4a55cd8c22d6eb47fc5c6b1e576c454f111 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.66e-05 | 184 | 95 | 5 | fa38d6a8709f520a027ad7e3ff783c84187ec467 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.16e-05 | 188 | 95 | 5 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.29e-05 | 189 | 95 | 5 | 63449d9f1e78ff2bc8786eb88a0d177fe30c7f4d | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.43e-05 | 190 | 95 | 5 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | (04)_Pre-ciliated|World / shred by cell type and Timepoint | 5.56e-05 | 191 | 95 | 5 | 37cf121e6e80760c8519075b7845b9029958a988 | |
| ToppCell | T_cells-Central_memory_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.56e-05 | 191 | 95 | 5 | 25dd538d6a361bd3367c8a1c0dfc9e7003061af3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 193 | 95 | 5 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 193 | 95 | 5 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 193 | 95 | 5 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.84e-05 | 193 | 95 | 5 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.99e-05 | 194 | 95 | 5 | 7a66bd7d4fc9c6db861cedd2487f241e406869d1 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.99e-05 | 194 | 95 | 5 | ae6d5cf4c825b29e677296df2c0985431c83b82e | |
| ToppCell | (7)_MNP-(7)_DC_1|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 5.99e-05 | 194 | 95 | 5 | 8dbe0188e2af6f14b3b44e5213fbdd581128082f | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.99e-05 | 194 | 95 | 5 | 4c40d6b50675eae52c419d69e719a9223df02ae3 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.99e-05 | 194 | 95 | 5 | 99a90de637e3babec2131cdd9f05ea965d8a8f30 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT2-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.99e-05 | 194 | 95 | 5 | 5bfc26668fa8f109f2ebc0d5fd98ab5bd219e62c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.14e-05 | 195 | 95 | 5 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.14e-05 | 195 | 95 | 5 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.14e-05 | 195 | 95 | 5 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.29e-05 | 196 | 95 | 5 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.44e-05 | 197 | 95 | 5 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 6.44e-05 | 197 | 95 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Cortical_neuron|3m / Sample Type, Dataset, Time_group, and Cell type. | 6.92e-05 | 200 | 95 | 5 | c248233b004f8ef0bab3c65ecfe295887966f2ee | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 6.92e-05 | 200 | 95 | 5 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 6.92e-05 | 200 | 95 | 5 | e4f0bb57be1112869c7068d0a789c2b802a442dd | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 6.92e-05 | 200 | 95 | 5 | e16bde12326f0cfc4d03f9307cba0e21ea2389cb | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 6.92e-05 | 200 | 95 | 5 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Intermediate|10w / Sample Type, Dataset, Time_group, and Cell type. | 6.92e-05 | 200 | 95 | 5 | e5a8647c47a49c8c90c78d681193946de103d8ff | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 6.92e-05 | 200 | 95 | 5 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.92e-05 | 200 | 95 | 5 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal-Unfolded_protein_responsible_cell|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 8.15e-05 | 107 | 95 | 4 | 7fee0193ee02e9cc62f506660ea7ec23fb4d0c84 | |
| ToppCell | COVID-19_Mild-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 1.35e-04 | 122 | 95 | 4 | 2aa9cfadab70312882ae679e3788fc7ab996c0f3 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Neuronal-Neurons|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 1.57e-04 | 49 | 95 | 3 | 46185fc61778d7a07f0eabaa934709e1b853dcf5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.14e-04 | 152 | 95 | 4 | 621e9b33cd3bb1c7b7d0633069f286b203e3d9c0 | |
| ToppCell | remission-unassigned|remission / disease stage, cell group and cell class | 3.30e-04 | 154 | 95 | 4 | 4130769829b838cc8a075c87ff6c187f0f507f8b | |
| ToppCell | COVID-CD4-antiviral_CD4|COVID / Condition, Cell_class and T cell subcluster | 3.38e-04 | 155 | 95 | 4 | 7e5ae034036fe85915d38a24195501e6d3bcbfb0 | |
| ToppCell | remission-unassigned|World / disease stage, cell group and cell class | 3.38e-04 | 155 | 95 | 4 | d81bec894381e3e2d6249a567e8108b8423e5c54 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Interneuron|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 3.46e-04 | 64 | 95 | 3 | fefabdf8d72a8f3caf78eb79d759edb475bdb2ad | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.64e-04 | 158 | 95 | 4 | 50df52d64d07178975563abd98ce4fddb9f2f7ef | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.09e-04 | 163 | 95 | 4 | ce07bc424ef99c547588b07f5c8b39ff0773ca9b | |
| ToppCell | 3'_v3-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Lung / Manually curated celltypes from each tissue | 4.09e-04 | 163 | 95 | 4 | 47300dec94dc66e965bf71fafff0a9fd24fae968 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.19e-04 | 164 | 95 | 4 | 1592a5becad7e0f3f990f0d7581d75fcfc7da023 | |
| ToppCell | NS-critical-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.28e-04 | 165 | 95 | 4 | 17d5c4a111d9b5400780bc5e7b93ce2f5d69ceb7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.38e-04 | 166 | 95 | 4 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.48e-04 | 167 | 95 | 4 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.48e-04 | 167 | 95 | 4 | 1e144c03409df94ccd39760842590e8ea7487e29 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.48e-04 | 167 | 95 | 4 | 784776d1fcc098f84d3c2eca58fa56cb9428f434 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.58e-04 | 168 | 95 | 4 | 95dc690c1987b05685d36e6bb20eb79308696e30 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.69e-04 | 169 | 95 | 4 | 0425d2580ed325178f522c0093ff4623de6ce7a8 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 4.69e-04 | 169 | 95 | 4 | 29db25e7c5f31d98a08a35d7ec5ade203242bc50 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.69e-04 | 169 | 95 | 4 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related-Oligodendrocyte/OPC|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 4.69e-04 | 169 | 95 | 4 | b1611e61f635f8f9b87250e026ad30999cbee041 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.69e-04 | 169 | 95 | 4 | fec669968a77060bd77ee8695034e35a642c984f | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.79e-04 | 170 | 95 | 4 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-04 | 170 | 95 | 4 | c638dfde9ce30190abbe0caea1c3eb874af09857 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.90e-04 | 171 | 95 | 4 | 1efce222989460bb59bd9fa955e7d9a60c73994c | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.90e-04 | 171 | 95 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.01e-04 | 172 | 95 | 4 | a03f30a996a9474ad4cccd209476423a042df002 | |
| ToppCell | Nasal_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.01e-04 | 172 | 95 | 4 | 04fabb40fa9357d8902f3b04adc15231626cd9f8 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.01e-04 | 172 | 95 | 4 | f92a53ad2e464cd68ba1714bcc1d5911479cdf1c | |
| ToppCell | Nasal_Brush-Epithelial-Ionocytes|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.01e-04 | 172 | 95 | 4 | dd3a23dc78dc6939f41126f8d7bd23a2e4713647 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-04 | 172 | 95 | 4 | 073a503dc922e3e3ac3528e249b0f8b74402110b | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.12e-04 | 173 | 95 | 4 | b9dee61973559e8c2fef3f2dafd43475b386befb | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-04 | 173 | 95 | 4 | 15af4a0f7516dbf5c93ba66a19aca073ebe30d04 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-04 | 176 | 95 | 4 | 25ebc8716aa44e44fce577701e3e82c6745a75ab | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-04 | 176 | 95 | 4 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-04 | 176 | 95 | 4 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-RGCs_early_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 5.46e-04 | 176 | 95 | 4 | 2a15437c5f5dbf6398d5ea70050632c24a7dc66c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.46e-04 | 176 | 95 | 4 | c7be4eaa5eb76ad9389fb9d15ad0934e88d267d1 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.46e-04 | 176 | 95 | 4 | cb8fd56a4f935cdda19d7ab43382cdda7c307667 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_26.46.91|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-04 | 176 | 95 | 4 | 29b71369503719c74888cd356ceb6724cfdcabd9 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.46e-04 | 176 | 95 | 4 | 437cfc5e06416bb0fc76d1f9dc106f74e279e880 | |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.66e-05 | 193 | 95 | 7 | 7232_DN | |
| Drug | Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; HL60; HT_HG-U133A | 1.83e-05 | 196 | 95 | 7 | 2974_DN | |
| Drug | Ramipril [87333-19-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.90e-05 | 197 | 95 | 7 | 6792_DN | |
| Drug | Droperidol [548-73-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.96e-05 | 198 | 95 | 7 | 5690_UP | |
| Drug | Avermectin B1 [71751-41-2]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 1.96e-05 | 198 | 95 | 7 | 7218_DN | |
| Drug | Antipyrine [60-80-0]; Up 200; 21.2uM; HL60; HG-U133A | 2.02e-05 | 199 | 95 | 7 | 1989_UP | |
| Drug | estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.09e-05 | 200 | 95 | 7 | 988_DN | |
| Disease | colon cancer (is_implicated_in) | 5.04e-06 | 36 | 93 | 4 | DOID:219 (is_implicated_in) | |
| Disease | cerebral microbleeds | 2.83e-05 | 19 | 93 | 3 | EFO_0010059 | |
| Disease | Lung diseases | 1.10e-04 | 78 | 93 | 4 | C0024115 | |
| Disease | leptin measurement | 1.28e-04 | 81 | 93 | 4 | EFO_0005000 | |
| Disease | Prostatic Neoplasms | 1.44e-04 | 616 | 93 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.44e-04 | 616 | 93 | 9 | C0376358 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 2.96e-04 | 41 | 93 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 2.96e-04 | 41 | 93 | 3 | C0858252 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 5.03e-04 | 49 | 93 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | response to statin, myopathy | 5.31e-04 | 11 | 93 | 2 | EFO_0004145, GO_0036273 | |
| Disease | Mouth Diseases | 6.35e-04 | 12 | 93 | 2 | C0026636 | |
| Disease | Cakut | 7.49e-04 | 13 | 93 | 2 | C1968949 | |
| Disease | Thyroid Diseases | 7.49e-04 | 13 | 93 | 2 | C0040128 | |
| Disease | colon cancer (is_marker_for) | 8.67e-04 | 59 | 93 | 3 | DOID:219 (is_marker_for) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 9.95e-04 | 139 | 93 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 1.00e-03 | 15 | 93 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | transitional cell carcinoma (is_marker_for) | 1.05e-03 | 63 | 93 | 3 | DOID:2671 (is_marker_for) | |
| Disease | stomach cancer (is_marker_for) | 1.08e-03 | 142 | 93 | 4 | DOID:10534 (is_marker_for) | |
| Disease | colorectal mucinous adenocarcinoma | 1.15e-03 | 16 | 93 | 2 | EFO_0009361 | |
| Disease | Mammary Carcinoma, Human | 1.38e-03 | 525 | 93 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.38e-03 | 525 | 93 | 7 | C1257931 | |
| Disease | Mammary Neoplasms | 1.41e-03 | 527 | 93 | 7 | C1458155 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 1.45e-03 | 18 | 93 | 2 | OBA_2045065 | |
| Disease | stomach cancer (is_implicated_in) | 1.54e-03 | 72 | 93 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | Breast Carcinoma | 1.58e-03 | 538 | 93 | 7 | C0678222 | |
| Disease | atherosclerosis (biomarker_via_orthology) | 1.80e-03 | 20 | 93 | 2 | DOID:1936 (biomarker_via_orthology) | |
| Disease | obsolete aging | 1.92e-03 | 279 | 93 | 5 | GO_0007568 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 2.04e-03 | 169 | 93 | 4 | DOID:3908 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | 2.06e-03 | 1074 | 93 | 10 | C0006142 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 2.09e-03 | 80 | 93 | 3 | DOID:1459 (biomarker_via_orthology) | |
| Disease | impotence (biomarker_via_orthology) | 2.18e-03 | 22 | 93 | 2 | DOID:1875 (biomarker_via_orthology) | |
| Disease | Bronchiectasis | 2.18e-03 | 22 | 93 | 2 | C0006267 | |
| Disease | medial orbital frontal cortex volume measurement | 2.81e-03 | 25 | 93 | 2 | EFO_0010315 | |
| Disease | breast cancer (is_marker_for) | 2.83e-03 | 185 | 93 | 4 | DOID:1612 (is_marker_for) | |
| Disease | Intellectual Disability | 2.94e-03 | 447 | 93 | 6 | C3714756 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VSDCSDGTSELEEPL | 186 | P50548 | |
| CEEDGVDTSEEDPTL | 206 | Q86X53 | |
| EESITLCLSGDEPDA | 286 | Q9BYV9 | |
| TTICSGHDADTEDDP | 141 | Q76N32 | |
| PDCLTDGSDVVSDLE | 136 | Q96G28 | |
| EGVCGASPEDEAEEE | 286 | P18089 | |
| TSDHEAEEPDCIISE | 341 | Q6XZF7 | |
| EEEEEVDLACTPTDV | 276 | P24385 | |
| IPGCEEEDASEISVS | 291 | Q8IYA2 | |
| LSEDEGVTEECADPE | 641 | Q13111 | |
| GCDSVTDTEPEDEKV | 146 | Q6ZUJ8 | |
| TELDCGIETDSGVDD | 166 | P42574 | |
| LCEEEEAASAPAVED | 256 | Q14444 | |
| GCPSASRAETDDEDD | 426 | Q9UER7 | |
| EPEDTADVESCGSNE | 101 | Q8IXJ9 | |
| DEEEVEEDGPSSCSE | 261 | Q9Y3T6 | |
| EELEPDREEDSSSCI | 411 | Q9NS91 | |
| IPEESEDCCEESSPT | 241 | Q6P2E9 | |
| ECEELGSDEGEVHTP | 931 | Q9UPP5 | |
| HCTSPALGEDELEEE | 156 | Q6Y2X3 | |
| ESEDESDILEESPCG | 21 | Q9NSY0 | |
| DSDESLDTCPEEVEI | 61 | Q9NZR2 | |
| ECPSITAEAALDSDE | 2521 | P78559 | |
| AEEPEEDGEEHVCVS | 951 | P46821 | |
| SPESEDEEEALPCTD | 971 | Q8N9B5 | |
| EDSENDETCAPLTED | 396 | Q86WP2 | |
| SDGSDEEECRIEPCT | 81 | Q9NPF0 | |
| EDVSSDTCPKEEDTE | 581 | Q9UPZ3 | |
| EVCDGDDDESSNEPE | 386 | Q8WVS4 | |
| DISDQEEDEESEGCP | 1766 | Q15154 | |
| EDEDHPGSGCSTSEE | 886 | O15018 | |
| VLPEDEDTEECEHLT | 476 | Q14999 | |
| DDEDLEECEPSTGGE | 1406 | Q9P2S2 | |
| DDPVDSDCDTDTTTD | 1961 | Q8NEV8 | |
| GCVPEEESSDGESDE | 106 | Q9UMN6 | |
| EGLCPDSATEEEDTV | 116 | Q9UKK3 | |
| SDPDSSEACAEEEEG | 221 | Q3MIN7 | |
| DDEEEEEQTCPSTFS | 476 | Q8IZ21 | |
| SLSDLTCTPEEEENE | 251 | Q6NV74 | |
| APEEEEDAGCRDLES | 281 | Q86XD5 | |
| LTEGPECDVTDDITA | 91 | Q6UXL0 | |
| LVASAECPSDDEDLE | 351 | P58401 | |
| DEDLEECEPSTGGEL | 361 | P58401 | |
| SSEENLSSEDEELPC | 1211 | P38398 | |
| KESCPSSDEVDEEEE | 266 | Q8N4S0 | |
| TDDDDDDCGTIDELP | 1451 | Q9P2D3 | |
| VSDDVVSPDEEGICS | 1751 | Q96N67 | |
| SEDTLSPDEDGVCAG | 1706 | Q8NF50 | |
| DVESLELEEDVCGAP | 16 | Q9Y5R5 | |
| RPVDEGEECSDSEGS | 326 | Q6Y7W6 | |
| ASCPLDSDLSEDEDL | 241 | P25686 | |
| KCPEILSDESSSDED | 221 | P35659 | |
| IPGCEEEDASEISVS | 341 | Q3MJ40 | |
| DEEDEDSPSECHTPE | 331 | O15033 | |
| SCDSPDTPETDDSIE | 481 | Q6P0Q8 | |
| CIDDLPDLEDDDETG | 546 | Q8NEP3 | |
| TVKDCDPTTGETDDE | 731 | Q9Y678 | |
| SSELEEPSLVCEEDE | 286 | Q86X24 | |
| IPGCEEEDASEISVS | 341 | A2RUR9 | |
| TLDSEEEGPLEECLA | 326 | Q8NFF5 | |
| PEELCDPEESSASGE | 231 | P39059 | |
| GPDSSEDACEDDSRL | 386 | Q6PJW8 | |
| STALEDCISVDEEGP | 361 | Q5VW36 | |
| PVREDESEVDGDCSL | 301 | Q8TBX8 | |
| TPESCPELSDEEQDG | 781 | Q9H0X9 | |
| SESEEEDLPVGEEVC | 66 | O14654 | |
| EATEEAEEGEHRTPC | 251 | Q3SY00 | |
| LQEVDCGSPSSSEEE | 311 | Q13671 | |
| DAQSDDVPDITSDEC | 671 | Q6ZMZ0 | |
| DAGTEPHTSEDECEP | 731 | Q7Z6B7 | |
| KDLCPSEGESDAEAE | 366 | O15119 | |
| DCTLIEEPDASDDDS | 526 | O14827 | |
| SSDDEDFVECEPSTG | 316 | Q9HDB5 | |
| ATCSADEDVDGEPER | 881 | O75376 | |
| TEECGEDRLPKSDSE | 486 | Q14524 | |
| EEGSVPETELLGDCD | 916 | Q01974 | |
| PEDTAESQASDELEC | 6 | Q8N6D2 | |
| DEDEVDANSSDCEPE | 466 | Q6ZRS2 | |
| IDCTLLEEPESTEEE | 521 | Q13972 | |
| CSGSFPTDKEEEDEE | 981 | Q9HAW4 | |
| VDSDSEVSEESPCES | 136 | Q8N427 | |
| TDTCELPEREEGEGE | 1041 | Q8NI35 | |
| GRTAEDTVEDACPAE | 451 | Q7Z6L1 | |
| TDTGVCSGTDEDPDD | 576 | Q5JSH3 | |
| ESEKGDEEVCEPAVS | 281 | Q9HBU9 | |
| DPGDSEEDTELSCTR | 306 | O14492 | |
| CDSTLGGDIRESDPE | 311 | O95947 | |
| DAIEADSEGDAEPCD | 61 | Q9Y3B9 | |
| PSETEQSETDCDVGE | 161 | Q9UBS9 | |
| CTEDTDQAEGTESEP | 356 | Q9HC78 | |
| SVTDAADCEGVPEDD | 46 | P37275 | |
| CSDKDEPDLDGDVSS | 251 | Q9Y2I8 | |
| EADSPSSSEEEPEVC | 466 | P10827 | |
| SSSEEEPEVCEDLAG | 471 | P10827 | |
| DCEETTEEAGREPVA | 101 | Q8N3L3 | |
| EECSPHLEDVSLSEE | 96 | Q96NJ3 | |
| SSCEELHPDEIDTDS | 1346 | P35125 | |
| RPCTSLSDGEEDEDD | 691 | Q9UGI0 | |
| VPHEDICEDSDIDGD | 51 | O00629 | |
| EAEREETTSPECEEH | 1286 | Q5VU43 |